Ofatumumab Interactions
There are 177 drugs known to interact with ofatumumab, along with 5 disease interactions. Of the total drug interactions, 50 are major, and 127 are moderate.
- View all 177 medications that may interact with ofatumumab
- View ofatumumab disease interactions (5)
Most frequently checked interactions
View interaction reports for ofatumumab and the medicines listed below.
- Actimmune (interferon gamma-1b)
- Adcetris (brentuximab)
- Adcirca (tadalafil)
- Adderall (amphetamine / dextroamphetamine)
- Adderall XR (amphetamine / dextroamphetamine)
- Adriamycin (doxorubicin)
- Advil (ibuprofen)
- Afinitor Disperz (everolimus)
- Aimovig (erenumab)
- Ajovy (fremanezumab)
- Ambien (zolpidem)
- Amrix (cyclobenzaprine)
- Andexxa (coagulation factor Xa)
- Arava (leflunomide)
- Arcapta (indacaterol)
- Aubagio (teriflunomide)
- Austedo (deutetrabenazine)
- Avelox I.V. (moxifloxacin)
- Avonex (interferon beta-1a)
- Copaxone (glatiramer)
- Cytoxan (cyclophosphamide)
- Emgality (galcanezumab)
- Klonopin (clonazepam)
- Librium (chlordiazepoxide)
- Lyrica (pregabalin)
- Plegridy (peginterferon beta-1a)
- Prozac (fluoxetine)
- Rybelsus (semaglutide)
- Tecfidera (dimethyl fumarate)
- Zonegran (zonisamide)
Ofatumumab disease interactions
There are 5 disease interactions with ofatumumab which include:
- Anti-CD20 antibodies – hepatitis B
- Anti-CD20 antibodies – infections
- tumor lysis syndrome
- cardiopulmonary disease
- cytopenias
Report options
QR code containing a link to this page
More about ofatumumab
- ofatumumab consumer information
- Compare alternatives
- Reviews (74)
- Side effects
- Dosage information
- During pregnancy
- Drug class: CD20 monoclonal antibodies
- Breastfeeding
Related treatment guides
Drug Interaction Classification
| Highly clinically significant. Avoid combinations; the risk of the interaction outweighs the benefit. | |
| Moderately clinically significant. Usually avoid combinations; use it only under special circumstances. | |
| Minimally clinically significant. Minimize risk; assess risk and consider an alternative drug, take steps to circumvent the interaction risk and/or institute a monitoring plan. | |
| No interaction information available. |
Further information
Always consult your healthcare provider to ensure the information displayed on this page applies to your personal circumstances.
